Latest filing published 30 Mar 2017 for Reata Pharmaceuticals INC, €9.4M.
Filing timeline
BuySaleInsider track record
No signal scores available.
AbbVie Inc.: trading record in brief
All filings by AbbVie Inc. on record concern Reata Pharmaceuticals Inc. The record holds 2 filings, for trades running from 2 February 2017 to 28 March 2017.
Every open-market trade on record is a sale: 1 sale worth €9.4M.
The record was last updated on 30 March 2017 with an open-market sale (€9.4M) in Reata Pharmaceuticals Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to AbbVie Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 450,000 shares@ US$22.50100.0% of flowClass A Common StockSEC:0001179110-17-005277:0
- 1,505,241 sharesClass A Common StockSEC:0001179110-17-002818:0
2 of 2 declarations
